Sort
25,944 grants matching “neurodegeneration”
Investigating Resistance and Resilience Mechanisms in Alzheimerâs Disease
$810,339Prashanthi Vemuri · Mayo Clinic Rochester · R01 · FY2023 · AG
Subjective Cognitive Decline in OIder Adults
$810,338Katherine A. Gifford · Vanderbilt University Medical Center · R01 · FY2022 · AG
Cryptic exon splicing mediated by TDP-43 loss of function as the underlying mechanism of pathogenesis in FTLD-TDP
$810,301Aaron D. Gitler · Stanford University · U54 · FY2022 · NS
Gut-brain axis in Alzheimer's disease: translational 7T MRI markers and underlying mechanisms
$810,065Ai-Ling Lin · University Of Missouri-Columbia · R56 · FY2023 · AG
CSF Clearance in Sporadic Alzheimer's Disease
$809,831Yi Li · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AG
Clinical Core
$809,789Sandra Weintraub · Northwestern University At Chicago · P30 · FY2024 · AG
Clinical Core
$809,789Sandra Weintraub · Northwestern University At Chicago · P30 · FY2022 · AG
A Longitudinal Study of Periodontal Infections and Alzheimer's Disease: The WHICAP Ancillary Study of Oral Health
$809,780James McCallum Noble · Columbia University Health Sciences · R01 · FY2021 · AG
Genetic etiology of Amyotrophic Lateral Sclerosis
$809,613Bryan Traynor · National Institute On Aging · ZIA · FY2015 · AG
Admin Core - Phase 2
$809,507Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2025 · GM
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in AlzheimerâÂÂs disease
$809,297Oleg Butovsky · Brigham And Women'S Hospital · R01 · FY2021 · AG
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimer's disease
$809,297Oleg Butovsky · Brigham And Women'S Hospital · R01 · FY2020 · AG
Relaxivity Contrast Imaging as Biomarker of Muscle Degeneration in ALS
$809,219Christopher Chad Quarles · St. Joseph'S Hospital And Medical Center · R61 · FY2022 · NS
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells
$809,186Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2024 · NS
Baylor Fragile X Research Center
$809,021Baylor College Of Medicine · P30 · FY2003 · HD
CHCHD10 Frontotemporal Dementia, Molecular Mechanisms and Therapeutic Strategies
$808,996Hibiki Fujita · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · NS
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$808,590Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA
Biology of Prion Protein and the TSE Diseases
$808,228Bruce Chesebro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Programs for generating inhibitory interneuron diversity and connectivity
$808,003Kristin Kay Baldwin · Columbia University Health Sciences · R01 · FY2025 · MH
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease
$807,979Timothy J Hohman · Vanderbilt University Medical Center · R01 · FY2023 · AG
Regulation of HIV latency by microglial-neuronal interactions
$807,952Jonathan Karn · Case Western Reserve University · R01 · FY2019 · DA
A futility trial of sirolimus in multiple system atrophy
$807,858Horacio Kaufmann · New York University School Of Medicine · R01 · FY2018 · NS
Cerebrovascular Remodeling and Neurodegenerative Changes in Alzheimer's Disease
$807,685Yanhang Katherine Zhang · Boston University (Charles River Campus) · R01 · FY2023 · AG
Brain Vascularity in Cardiac Surgery & Neurodegeneration
$807,571Dixon M Moody · Wake Forest University Health Sciences · R01 · FY2006 · NS
Elucidating clinical heterogeneity in early-onset AD via genomics, transcriptomics, and neuroimaging
$807,400Jennifer S Yokoyama · University Of California, San Francisco · R01 · FY2023 · AG